UroGen Pharma Ltd. (URGN)

CIK 1668243 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for UroGen Pharma Ltd..

Recent SEC filings

FiledFormAccession number
Nov 4, 2026S-80001437749-26-034945
Nov 4, 202610-Q0001437749-26-034780
Nov 4, 20268-K0001437749-26-034769
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003732
Oct 9, 20261440001976408-26-000887
Oct 9, 202640001437749-26-032421
Sep 9, 20261440001976408-26-000810
Sep 9, 20261440001976408-26-000811
Sep 9, 202640001437749-26-029963
Sep 9, 202640001437749-26-029965
Aug 28, 202640001437749-26-029175
Aug 24, 202640001437749-26-028840
Aug 20, 20261440001000275-26-000100
Aug 20, 20268-K0001437749-26-028590
Aug 12, 2026SCHEDULE 13G/A0000947263-26-000072
Aug 5, 20268-K0001437749-26-025793
Aug 5, 202610-Q0001437749-26-025794
Jul 10, 202640001437749-26-023290
Jul 9, 20261440001000275-26-000093
Jun 24, 202640001437749-26-021523
Jun 24, 202640001437749-26-021513
Jun 24, 202640001437749-26-021509
Jun 24, 202640001437749-26-021515
Jun 24, 202640001437749-26-021519
Jun 24, 202640001437749-26-021511